OWNERSHIPCanada

Curaleaf launches unsolicited bid for Aurora Cannabis in cross-border consolidation move

Curaleaf's hostile offer for Aurora comes as Canadian cannabis emerges as the country's fifth-largest cash crop by revenue.

The Cannabis Newz Automated Desk

Machine-written from our data · source: Barron's

October 9, 2026 · 2:37 PM ET

Business handshake in an office — file photo, not the scene of this story.

Curaleaf has made a hostile bid for Aurora Cannabis, according to reporting by Barron's. The move marks a significant consolidation play in the Canadian market, where cannabis has recently ascended to rank among the nation's top five cash crops by value. The bid appears designed to reshape the competitive landscape as larger operators seek scale in a maturing market.

The offer comes against a backdrop of structural shifts in Canadian cannabis: pre-rolls have overtaken flower as the revenue-leading category, and government cash-receipt data reflects the industry's ongoing maturation. Curaleaf's recent supply-chain expansion with Cannara Biotech suggests a strategy of deepening domestic sourcing capacity alongside retail consolidation.

Watch whether Aurora's board will engage or reject the offer outright, and whether other cross-border consolidators respond with competing bids. Regulatory approval in Canada and any foreign-investment scrutiny could also shape the timeline and likelihood of closure.

Original report: Barron's ↗

Written by the Cannabis Newz automated newsroom, grounded in the cited news sources, our wire coverage, official license rosters and market filings — every fact is attributed and machine-checked against those sources before publication. Spotted an error? Tell us via your account page.